Filter Results:
(4,839)
Show Results For
- All HBS Web
(4,839)
- People (17)
- News (1,875)
- Research (2,381)
- Events (2)
- Multimedia (212)
- Faculty Publications (1,875)
Show Results For
- All HBS Web
(4,839)
- People (17)
- News (1,875)
- Research (2,381)
- Events (2)
- Multimedia (212)
- Faculty Publications (1,875)
- 06 Oct 2008
- Research & Ideas
Updating a Classic: Writing a Great Business Plan
which has a negative effect on all ventures, sensible and nonsensical. I would also reinforce the idea that entrepreneurship is critical around the world. We are confronted with many crises from health care... View Details
Keywords: by Sean Silverthorne
- 22 Feb 2023
- Blog Post
Meet the Disability Advocacy and Affinity Group (DAAG)
The Disability Advocacy and Affinity Group (DAAG)) has a mission to destigmatize the experience of living with or being the caretaker of someone with a disability. We cherish the unique perspectives that individuals with disabilities bring to every academic,... View Details
- 25 Mar 2021
- Blog Post
Meet the Student Academic Services Support Team at HBS!
the myriad social and co-curricular opportunities available during their time here. So how can they help? The MBA Student & Academic Services Support Services team provides direct support, counseling, and advising to all HBS students on academic and personal... View Details
- 16 Mar 2020
- Research & Ideas
How the Coronavirus Is Already Rewriting the Future of Business
With COVID-19 cases growing worldwide, business leaders are scrambling to deal with a wide variety of problems, from slumping sales and stalling supply chains to keeping employees healthy and making sure they can continue working. We asked professors of Harvard... View Details
Keywords: by Dina Gerdeman
Joey Ryu
Joey (Won Jung) Ryu is a doctoral student in the Strategy unit at Harvard Business School. Her primary interests are strategic management, economics of innovation and entrepreneurship. Prior to joining HBS, Joey received her master's degree from Cornell University... View Details
- 21 Aug 2000
- Research & Ideas
Inside the OR: Disrupted Routines and New Technologies
technologies. Successful teams in the study led open and deliberate efforts to expand the boundary of MICS awareness into related areas of the hospital such as the cardiology and intensive care units. A nurse described her role, "We... View Details
Keywords: by Hilah Geer
- September 2009
- Case
The Risk Management Foundation of the Harvard Medical Institutions, Inc.
By: Richard M.J. Bohmer, Stephen P. Bradley and Natalie Kindred
Through its uniquely proactive approach to medical malpractice risk management, the Risk Management Foundation (RMF) has decreased claims—and premiums—for the Harvard hospitals it insures. The RMF is the captive medico-legal insurer of the Harvard medical institutions... View Details
Keywords: Cost Management; Insurance; Health Care and Treatment; Risk Management; Performance Improvement; Safety; Health Industry; Health Industry; Boston
Bohmer, Richard M.J., Stephen P. Bradley, and Natalie Kindred. "The Risk Management Foundation of the Harvard Medical Institutions, Inc." Harvard Business School Case 610-014, September 2009.
- 30 Mar 2021
- Research & Ideas
Commuting Hurts Productivity and Your Best Talent Suffers Most
negative health outcomes, including heart disease—Wu says this is the first study to analyze the impact on the innovation generated by firms and their workers. The research team analyzed a sample of 3,445 inventors and 1,180 firms in... View Details
Keywords: by Lane Lambert
- 31 Jan 2014
- Working Paper Summaries
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
- December 2023
- Teaching Note
Buurtzorg
By: Ethan Bernstein and Tatiana Sandino
Teaching Note for HBS Case No. 122-101. As co-founders of home nursing company Buurtzorg, Jos de Blok and Gonnie Kronenberg prized both self-management and organizational learning. Buurtzorg’s 10,000 nurses across 950 neighborhood nursing teams in the Netherlands were... View Details
- October 2022
- Case
Cost Plus Drugs
By: Alexander MacKay and James Barnett
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies.... View Details
Keywords: Business Ventures; Decision Making; Entrepreneurship; Ethics; Health; Markets; Social Enterprise; Society; Strategy; Health Care and Treatment; Business Divisions; Factories, Labs, and Plants; Health Industry; Health Industry; United States; Texas
MacKay, Alexander, and James Barnett. "Cost Plus Drugs." Harvard Business School Case 723-362, October 2022.
- 01 Jun 2023
- News
Curb Appeal
residents depend on sanitation every single day—to empty the litter bins, sweep and plow the streets, pick up the trash and recycling, and more. “If we don’t do our job for one day, pretty much everyone notices,” she says. “If we don’t do it for two or three days, it’s... View Details
- 16 Jul 2020
- Research & Ideas
Restaurant Revolution: How the Industry Is Fighting to Stay Alive
policies with exclusions. Thanks, but no thanks to bailouts Our panelists expressed frustration with government aid programs, such as the US CARES Act and its Paycheck Protection Program (PPP) enacted in late March. Although designed to... View Details
- Web
Regional Winners - Alumni
fun, reliable, effective, eco-friendly personal care brand focusing on children and teenagers who have their own age-specific needs and preference. Tingting Zhong, MBA 2006, Co-founder & Co-CEO Region: Asia/Pacific Deeper Pulse Deeper... View Details
- March 2022 (Revised July 2022)
- Case
Nexleaf Analytics: Saving the World Using the Internet of Things
By: Frank Nagle
In 2019, a decade after co-founding Nexleaf Analytics, CEO Nithya Ramanathan faced an important decision that would impact the ability of the small, but growing, not-for-profit organization to thrive for another decade. Their sensor technologies and big data analytics... View Details
Keywords: Corporate Strategy; Collaborative Innovation and Invention; Technological Innovation; Nonprofit Organizations; Competitive Strategy; Patents; Expansion; Information Technology; Health Industry; Information Industry; Medical Devices and Supplies Industry; Technology Industry
Nagle, Frank. "Nexleaf Analytics: Saving the World Using the Internet of Things." Harvard Business School Case 722-414, March 2022. (Revised July 2022.)
- November 2013 (Revised November 2014)
- Case
Infection Control at Massachusetts General Hospital
By: Robert S. Huckman and Nikolaos Trichakis
The case explores the challenges facing Massachusetts General Hospital concerning the adoption of a new infection control policy, which promises to improve operational performance, patient safety, and profitability. The new policy requires coordination between... View Details
Keywords: Safety; Organizational Change and Adaptation; Integration; Health Care and Treatment; Policy; Health Industry; Boston
Huckman, Robert S., and Nikolaos Trichakis. "Infection Control at Massachusetts General Hospital." Harvard Business School Case 614-044, November 2013. (Revised November 2014.)
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 03 Dec 2021
- Blog Post
Physicians Off the Beaten Path
Youssef is a medical doctor and the first Syrian Rhodes Scholar. He has an MD from Syria, an MSc in International Health at Oxford and is currently doing an MBA at Harvard Business School along with a PhD in computer science (clinical AI)... View Details
Alvin E. Roth
Al Roth is the George Gund Professor of Economics and Business Administration in the Department of Economics at Harvard University, and in the Harvard Business School. His research, teaching, and consulting interests are in game theory, experimental economics, and... View Details